News

Gene Therapy Pioneer Jim Wilson Comments on iECURE's Announcement of Complete Clinical Response for ECUR-506

January 9, 2025

Gene Therapy Pioneer Jim Wilson Comments on Solid Biosciences's Announcement of FDA IND Clearance for Friedreich's Ataxia Treatment

January 8, 2025

GEMMABio Appoints Dr. May Orfali as Chief Medical Officer

December 23, 2024

GEMMABio Secures $34 Million in Seed Funding to Drive Gene Therapy Advancements

GEMMABio Announces $100 Million Agreement with Brazil's Leading Health Research Institute

October 8, 2024

To Further Advance Gene Therapy Research, Industry Pioneer Jim Wilson is Forming Two Independent Companies Dedicated to Genetic Medicine

July 31, 2024

Geneticist Jim Wilson left UPenn behind, but not his dream of curing rare genetic diseases

May 27, 2025

GEMMABio rakes in $34M raise, a huge boost to the Philly life sciences scene 

January 27, 2025

UPenn gene therapy pioneer’s biotech gets $34 million in funding

December 24, 2024

Jim Wilson secures $100M for global approach aimed at reviving gene therapy field

'We can't waste money': Dr. James Wilson believes gene therapy needs a new business model

June 30, 2025

Abu Dhabi to partner with GEMMABio Therapeutics, advance gene therapies for children with spinal muscular atrophy

July 5, 2025

Jim Wilson's Gemma Bio enters into its second international gene therapy partnership

July 7, 2025

‘The Responsible Development of Adeno-Associated Virus Gene Therapies’
A commentary by Drs. Jim Wilson and Art Caplan published in Human Gene Therapy

July 11, 2025